ESQ
Esquire Financial Holdings, Inc.
ESQ's fundamentals are mixed, but it looks expensive: trading at 22x earnings, above its usual 14x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ESQ Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
ESQ's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like ESQ.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ESQ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $60.68 | -54% |
| Fair | 14x | $83.73 | -36% |
| Forward | 15x | $132 | — |
| Expensive | 18x | $108 | -18% |
| Current | 22x | $132 | — |
Historical ranges are pointers, not guarantees.
ESQ's PE is in its expensive range at 22x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its fair range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ESQ Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for ESQ, but weaker profitability.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ESQ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.80 | +47% |
| Q3 2026 | $6.00 | +5.6% |
| Q2 2026 | $6.05 | +12% |
| Q1 2026 | $5.94 | +13% |
| Q4 2025 | $5.87 | +14% |
| Q3 2025 | $5.68 | +15% |
| Q2 2025 | $5.40 | +13% |
| Q1 2025 | $5.27 | +14% |
| Q4 2024 | $5.14 | +4.7% |
ESQ has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ESQ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $61.4M | +63% |
| Q2 2026 | $42.1M | +18% |
| Q1 2026 | $40.5M | +20% |
| Q4 2025 | $39.4M | +19% |
| Q3 2025 | $37.6M | +18% |
| Q2 2025 | $35.8M | +17% |
| Q1 2025 | $33.8M | +15% |
| Q4 2024 | $33.1M | +14% |
ESQ's revenue has grown year over year for 10 quarters in a row: $61M last quarter, up 63% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | -8 points |
| Q2 2026 | 43% | +0.5 points |
| Q1 2026 | 42% | -3.7 points |
| Q4 2025 | 44% | -3.2 points |
| Q3 2025 | 46% | -2.3 points |
| Q2 2025 | 43% | -4.4 points |
| Q1 2025 | 46% | -0.8 points |
| Q4 2024 | 47% | +0.6 points |
ESQ has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ESQ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13M | -20% |
| Q2 2026 | $14.4M | +54% |
| Q1 2026 | $19.3M | +32% |
| Q4 2025 | $16.5M | +42% |
| Q3 2025 | $16.2M | +55% |
| Q2 2025 | $9.3M | +36% |
| Q1 2025 | $14.7M | +17% |
| Q4 2024 | $11.6M | -29% |
ESQ has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ESQ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +28% | +2.4M shares |
| 1 year | +28% | +2.5M shares |
| 3 years | +33% | +2.8M shares |
| 5 years | +40% | +3.2M shares |
| Available history | +43% | +3.4M shares |
ESQ has 11M diluted shares, up 28% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q1 2023 | $268,000 |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | $82,000 |
| Q1 2020 | $485,000 |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over ESQ on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ESQ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.8x | Net Cash |
| Q2 2026 | -3.4x | Net Cash |
| Q1 2026 | -3.2x | Net Cash |
| Q4 2025 | -3.5x | Net Cash |
| Q3 2025 | -3.7x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -2.8x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
ESQ has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like ESQ.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ESQ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.7 | Neutral |
| Stochastic | 75.2 | Neutral |
ESQ's weekly RSI is 64 (neutral) and its Stochastic is 75 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ESQ PE vs Financial Services Sector
| Metric | ESQ | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 13x | 69% above |
| PE % | 100 | 63 | 37 pts above |
ESQ is trading at 22x earnings, a 69% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ESQ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $123.6 | 6.5% above |
| 20 week MA | $122.4 | 7.6% above |
| 50 week MA | $113.9 | 16% above |
| 100 week MA | $101.8 | 29% above |
| 200 week MA | $76.0 | 73% above |
ESQ has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ESQ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.7 | $19.3 | -28% |
| 2021 | $19.3 | $31.3 | +63% |
| 2022 | $31.3 | $42.8 | +37% |
| 2023 | $42.8 | $50.0 | +17% |
| 2024 | $50.0 | $78.8 | +58% |
| 2025 | $78.8 | $105.0 | +33% |
| 2026 YTD | $105.0 | $131.7 | +25% |
ESQ has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.